Similar articles

• Proceedings: Effects of prostaglandins E1, E2 and D2 on platelet aggregation: variation with animal species and ionized calcium concentration.

  Gordon JL, MacIntyre DE. Gordon JL, et al. Br J Pharmacol. 1975 Oct;55(2):259P-260P. Br J Pharmacol. 1975. PMID: 1201399 Free PMC article. No abstract available.
• Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.

  Eggerman TL, Harker LA, Andersen NH, Wilson CH. Eggerman TL, et al. Adv Prostaglandin Thromboxane Res. 1980;6:389-93. Adv Prostaglandin Thromboxane Res. 1980. PMID: 6247888 No abstract available.
• Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems.

  Kawasaki A, Ishii K, Wakitani K, Tsuboshima M. Kawasaki A, et al. Adv Prostaglandin Thromboxane Res. 1980;6:331-6. Adv Prostaglandin Thromboxane Res. 1980. PMID: 6992531 No abstract available.
• [Inhibitors of thrombocyte aggregation].

  Lakin KM, Makarov VA, Novikova NV, Tret'iak VM. Lakin KM, et al. Farmakol Toksikol. 1983 May-Jun;46(3):113-26. Farmakol Toksikol. 1983. PMID: 6134634 Review. Russian. No abstract available.
• [Hematological implications of prostaglandins].

  Popa G, Nechifor M. Popa G, et al. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1978 Mar-Apr;30(2):117-22. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1978. PMID: 26950 Review. Romanian. No abstract available.